Balyasny Asset Management’s Longevity Health Holdings, Inc. Warrant XAGEW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-342,706
Closed -$7.95K 3562
2025
Q2
$7.95K Hold
342,706
﹤0.01% 2728
2025
Q1
$12.3K Hold
342,706
﹤0.01% 2718
2024
Q4
$19.3K Hold
342,706
﹤0.01% 2656
2024
Q3
$30K Hold
342,706
﹤0.01% 2655
2024
Q2
$24.8K Hold
342,706
﹤0.01% 2461
2024
Q1
$52.2K Hold
342,706
﹤0.01% 2525
2023
Q4
$78.8K Hold
342,706
﹤0.01% 2396
2023
Q3
$86.1K Hold
342,706
﹤0.01% 2133
2023
Q2
$68.5K Hold
342,706
﹤0.01% 2127
2023
Q1
$55.9K Hold
342,706
﹤0.01% 2376
2022
Q4
$57.1K Sell
342,706
-28,544
-8% -$4.98K ﹤0.01% 2330
2022
Q3
$110K Hold
371,250
﹤0.01% 2401
2022
Q2
$142K Hold
371,250
﹤0.01% 2243
2022
Q1
$290K Hold
371,250
﹤0.01% 1932
2021
Q4
$286K Hold
371,250
﹤0.01% 1755
2021
Q3
$382K Buy
+371,250
New +$447K ﹤0.01% 1536

Other funds holding XAGEW

Balyasny Asset Management's XAGEW Position: Q3 2025 in Review

Balyasny Asset Management sold out of Longevity Health Holdings, Inc. Warrant (XAGEW) in Q3 2025, closing a stake of 342,706 shares — an estimated $7.95K sold.

Balyasny Asset Management first reported a position in XAGEW in Q3 2021 and held it in 16 quarters. The position peaked at $382K in Q3 2021. 1 fund tracked by Wall St. Rank holds XAGEW as of Q3 2025.

  • Balyasny Asset Management reported no remaining Longevity Health Holdings, Inc. Warrant position as of Q3 2025 after selling out during the quarter.
  • Balyasny Asset Management sold 342,706 Longevity Health Holdings, Inc. Warrant shares in Q3 2025, an estimated $7.95K.
  • Balyasny Asset Management first reported a position in Longevity Health Holdings, Inc. Warrant in Q3 2021 and held it in 16 quarters.
  • Balyasny Asset Management's Longevity Health Holdings, Inc. Warrant position peaked at $382K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Longevity Health Holdings, Inc. Warrant as of Q3 2025.

Based on Balyasny Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.